Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Lakefront Biotherapeutics - Sponsored ADR (LKFT) Cost of Goods Sold data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
|
Cost of Goods Sold |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$3.70B |
|
$123.46M |
|
$408.99M |
|
$4.11B |
|
$428.48M |
|
-- |
|
$816.35M |
|
$1.24B |
|
$2.86B |
|
$2.85B |
|
$2.86B |
|
-- |
|
| Cash Flow Statement Financials | |
$-245.46M |
|
$252.71M |
|
$-3.35M |
|
$75.09M |
|
$75.34M |
|
$0.26M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|